Kiromic Biopharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Kiromic BioPharma is holding its annual meeting on June 26, 2024, seeking stockholder approval for director elections, auditor ratification, a share cap proposal, and a reverse stock split.